202 related articles for article (PubMed ID: 9466172)
21. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
22. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
24. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
25. A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.
Søgaard J; Lane R; Latimer P; Behnke K; Christiansen PE; Nielsen B; Ravindran AV; Reesal RT; Goodwin DP
J Psychopharmacol; 1999 Dec; 13(4):406-14. PubMed ID: 10667618
[TBL] [Abstract][Full Text] [Related]
26. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
27. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
Berlin I; Saïd S; Spreux-Varoquaux O; Launay JM; Olivares R; Millet V; Lecrubier Y; Puech AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):444-52. PubMed ID: 7586937
[TBL] [Abstract][Full Text] [Related]
28. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
29. Moclobemide in social phobia: a controlled dose-response trial.
Noyes R; Moroz G; Davidson JR; Liebowitz MR; Davidson A; Siegel J; Bell J; Cain JW; Curlik SM; Kent TA; Lydiard RB; Mallinger AG; Pollack MH; Rapaport M; Rasmussen SA; Hedges D; Schweizer E; Uhlenhuth EH
J Clin Psychopharmacol; 1997 Aug; 17(4):247-54. PubMed ID: 9241002
[TBL] [Abstract][Full Text] [Related]
30. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
31. Moclobemide versus tranylcypromine in the treatment of depression.
Rossel L; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
[TBL] [Abstract][Full Text] [Related]
32. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Laux G; Beckmann H; Classen W; Becker T
J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
[TBL] [Abstract][Full Text] [Related]
33. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
[TBL] [Abstract][Full Text] [Related]
34. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
Gabelic I; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():44-5. PubMed ID: 2248068
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Steinmeyer EM; Vorbach EU; Arnoldt KH
Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
[TBL] [Abstract][Full Text] [Related]
36. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
37. New antidepressants: use in high-risk patients.
Hale AS
J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707
[TBL] [Abstract][Full Text] [Related]
38. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
39. Medication treatments for panic disorder and social phobia.
Stein MB
Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
[TBL] [Abstract][Full Text] [Related]
40. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
Barrelet L; Blajev B; Bolzani L; de Saussure C; Kasas A; Van H; Gachoud JP
Schweiz Rundsch Med Prax; 1991 May; 80(19):524-8. PubMed ID: 1904620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
